相关实验视频
Updated: Jun 4, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.4K
在儿童群体中严重的酸性喘的预后因素:西班牙的一项前性队列研究
Clara Padró-Casas1, María Basagaña1, María Del Mar Martínez-Colls2
1Allergy Section, Severe Asthma Unit, Hospital Universitari Germans Trias i Pujol, Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Carretera de Canyet s/n, 08916 Badalona, Spain.
Journal of clinical medicine
|December 17, 2024
概括
在儿科严重的乙酸性喘中,症状控制和喘持续时间是疾病不受控制的关键因素. 没有确定可靠的生物标志物来预测这些儿童的结果.
科学领域:
- 儿科肺病学 儿科肺病学
- 过敏和免疫学 过敏和免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 在儿童中,严重的乙酸性喘在管理和预测结果方面存在独特的挑战.
- 关于预后因素和生物标志物的真实数据对于改善患者护理至关重要.
研究的目的:
- 为了确定儿童严重酸性喘的预后因素.
- 评估潜在的生物标志物来预测儿科患者的喘结果.
主要方法:
- 一个前性队列研究59名儿童 (年龄在6-17岁) 患有严重的酸性喘.
- 收集的数据包括喘控制 (ACT),肺功能 (FEV1),恶化,FeNO和各种炎症生物标志物.
- 在基线和12个月后进行了后续评估.
主要成果:
- 83.1%的儿童在基线时患有无法控制的喘,在52.5%的儿童中症状控制不良 (ACT <20).
- 喘持续时间 (OR=1.23) 和较低的ACT得分 (OR=0.80) 与1年后无法控制的喘显著相关.
- 唾液中的乙氨基酸与血液中的乙氨基酸,FeNO或血清质素没有相关性;没有确定预测生物标志物.
结论:
- 儿科严重的乙酸性喘通常具有过敏表型,症状是失控疾病的主要驱动因素.
- 目前的生物标志物缺乏预测能力,无法预测这个人群的结果.
- 需要进一步的研究,以更好地表型表征和生物标志物调查儿科严重的酸性喘.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
348
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
348
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K

